The Blood Glucose Monitoring Device market is anticipated to reach over USD 2.61 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the orthopedic treatment dominated the global Blood Glucose Monitoring Device market, in terms of revenue. Asia-Pacific is expected to be the leading contributor to the global market revenue in 2017.
The
increasing need for home care diagnosis and real time data by the end users to
primarily drive the blood glucose monitoring device market during the forecast
period. These devices have potential market due to the rising technology
advancements in this industry during the forecast period. Moreover, the major
supporting factor for this market growth is the number of populations suffering
from diabetes. According to the World Health Organization (WHO), approximately
there were direct deaths if 1.6 million in 2015, and this number is attributed
to rise by 2030 making diabetes the 7th leading
cause of death globally.
Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/blood-glucose-monitoring-device-market/request-for-sample
Furthermore,
the changing life style of the people, and rising preference to the sedentary
life style to also support the market growth in the coming years. However, lack
of awareness, limited use of these devices, and no proper reimbursements
regulation by the government would impede the market growth during the forecast
period.
North
America generated the highest revenue in the Blood Glucose Monitoring Device
market in 2017, and is expected to be the leading region globally during the
forecast period. Increasing demand, rising patient awareness for proper
self-diagnosis methods, which saves the time, money, and provides accurate
real-time data about the patient health. Also, decreasing cost & time of
treatment, and continuous research and development in the same field to also
boost the market growth in coming years. While, Asia Pacific blood glucose
monitoring device market is supposed to the fastest growing market during
forecast period.
Do you have questions or special
requirements? Ask our industry Experts: https://www.polarismarketresearch.com/industry-analysis/blood-glucose-monitoring-device-market/speak-to-analyst
The
key players operating in the Blood Glucose Monitoring Device market include
Abbott Laboratories, Terumo Corporation, ARKRAY Inc., Medtronic Plc., Acon
Laboratories Inc., Roche Diagnostics Ltd., Johnson & Johnson, Novo Nordisk
A/S, Becton, Dickinson and Co., Sanofi, Bayer AG, Ypsomed AG. These companies
launch new products and collaborate with other market leaders to innovate and
launch new products to meet the increasing needs and requirements of consumers.
No comments:
Post a Comment
Please do not enter any spam link in the comment box...